RILEXINE 200 LC

Država: Novi Zeland

Jezik: engleski

Izvor: Ministry for Primary Industries

Aktivni sastojci:

cephalexin

Dostupno od:

Virbac New Zealand Ltd

INN (International ime):

cephalexin

Sastav:

cephalexin 20 g/litre

Područje terapije:

Antibiotic

Status autorizacije:

ACVM Registered

Datum autorizacije:

1998-07-08

Svojstava lijeka

Label Text – Rilexine 200LC
June 2020
Left Panel
ACTIVE INGREDIENTS
(per 10mL syringe)
200mg cephalexin as cephalexin monohydrate
INDICATIONS
For the treatment of acute and chronic mastitis in lactating cows due
to cephalexin-
sensitive organisms. These include Staphylococcus aureus,
Streptococcus uberis, S.
agalactiae, S. dysgalactiae and Escherichia coli.
DOSAGE AND ADMINISTRATION
Milk out infected quarter and disinfect teat tip. Infuse the entire
contents of syringe
into the infected quarter. Gently massage the udder to aid dispersal
of Rilexine
®
200
LC through the udder tissue.
Repeat at each milking for 3-4 milkings.
WITHOLDING PERIODS
It is an offence for users of this product to cause residues exceeding
the relevant
MRL in the Food Notice: Maximum Residue Levels for Agricultural
Compounds.
Milk: 4 milkings (4 x 12 hours)
Meat: 4 days
Store at or below 25ºC
KEEP OUT OF REACH OF CHILDREN
Registered pursuant to the ACVM Act 1997, A7662
See www.foodsafety.govt.nz for registration conditions
Registered to and distributed by
Virbac New Zealand Limited
26 – 30 Maui Street
Pukete Park, Hamilton
Visit us at www.virbac.co.nz
Batch:
Expiry:
Right Panel
FOR ANIMAL TREATMENT ONLY
RESTRICTED VETERINARY MEDICINE
Rilexine

200 LC
INTRAMAMMARY TREATMENT FOR MASTITIS
IN THE LACTATING COW
Carton Text – Rilexine
June 2020
Front Panel
FOR ANIMAL TREATMENT ONLY
RESTRICTED VETERINARY MEDICINE
Rilexine

200 LC
INTRAMAMMARY TREATMENT FOR MASTITIS
IN THE LACTATING COW
Net Contents: 20 syringes
Back Panel
ACTIVE INGREDIENTS (per 10mL syringe)
200mg cephalexin as cephalexin monohydrate
INDICATIONS
For the treatment of acute and chronic mastitis in lactating cows due
to cephalexin-
sensitive organisms. These include Staphylococcus aureus,
Streptococcus uberis, S.
agalactiae, S. dysgalactiae and Escherichia coli.
DESCRIPTION
Rilexine
®
200LC is an intramammary formulation of cephalexin (200mg) in a quick
release arachis oil base. Cephalexin is a first-generation
cephalosporin which is
effective against Gram-positive bac